Intracellular rate-limiting steps in MHC class I antigen processing

Journal of Immunology

Volumn 163, Issue 4, 1999, Pages 1914-1922

  Montoya, María ^a,b   Del Val, Margarita ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b Churchill Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VACCINIA VIRUS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; ANTIGENS, NEOPLASM; BETA-GALACTOSIDASE; CELLS, CULTURED; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTRACELLULAR FLUID; KINETICS; MAST-CELL SARCOMA; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VACCINIA VIRUS;

EID: 0033566953     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Groettrup, M., A. Soza, U. Kuckelkorn, and P. M. Kloetzel. 1996. Peptide antigen production by the proteasome: complexity provides efficiency. Immunol. Today 17:429.
2. Lopez, D., and M. Del Val. 1997. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation. J. Immunol. 159:5769.
3. Gil-Torregrosa, B., A. R. Castano, and M. Del Val. 1998. MHC class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin. J. Exp. Med. 188:1.
4. Elliott, T. 1997. How does TAP associate with MHC class I molecules? Immunol. Today 18:375.
5. York, I. A., and K. L. Rock. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369.
6. Koopmann, J. O., G. J. Hammerling, and F. Momburg. 1997. Generation, intracellular transport and loading of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 9:80.
7. Iezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8:89.
8. Del Val, M., H. J. Schlicht, T. Ruppert, M. J. Reddehase, and U. H. Koszinowski. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66: 1145.
9. Eisenlohr, L. C., J. W. Yewdell, and J. R. Bennink. 1992. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med 175:481.
10. Villanueva, M. S., P. Fischer, K. Feen, and E. G. Pamer. 1994. Efficiency of MHC class I antigen processing: a quantitative analysis. Immunity 1:479.
11. Vijh, S., I. M. Pilip, and E. G. Pamer. 1998. Effect of antigen-processing efficiency on in vivo T cell response magnitudes. J. Immunol. 160:3971.
12. Anton, L. C., J. W. Yewdell, and J. R. Bennink. 1997. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J. Immunol. 158:2535.
13. Porgador, A., J. W. Yewdell, Y. P. Deng, J. R. Bennink, and R. N. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide MHC class I complexes using a monoclonal antibody. Immunity 6:715.
14. Grant, E. P., M. T. Michalek, A. L. Goldberg, and K. L. Rock. 1995. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class 1 presentation. J. Immunol. 155:3750.
15. Benham, A. M., and J. J. Neefjes. 1997. Proteasome activity limits the assembly of MHC class I molecules after IFN-γ stimulation. J. Immunol. 159:5896.
16. White, L. C., K. L. Wright, N. J. Felix, H. Ruffner, L. F. L. Reis, R. Pine, Ting, and JPY. 1996. Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8(+) T cells in IRF-1(-/-) mice. Immunity 5:365.
17. David-Watine, B., A. Israel, and P. Kourilsky. 1990. The regulation and expression of MHC class I genes. Immunol. Today 11:286.
18. Geginat, G., T. Ruppert, H. Hengel, R. Holtappels, and U. H. Koszinowski. 1997. IFN-γ is a prerequisite for optimal antigen processing of viral peptides in vivo. J. Immunol. 158:3303.
19. Moss, B. 1996. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc. Natl. Acad. Sci. USA 93:11341.
20. Davison, A. J., and B. Moss. 1989. Structure of vaccinia virus early promoters. J. Mol. Biol. 210:749.
21. Dick, L. R., C. Aldrich, S. C. Jameson, C. R. Moomaw, B. C. Pramanik, C. K. Doyle, G. N. DeMartino, M. J. Bevan, J. M. Forman, and C. A. Slaughter. 1994. Proteolytic processing of ovalbumin and β-galactosidase by the proteasome to yield antigenic peptides. J. Immunol. 152:3884.
22. Rammensee, H. G., H. Schild, and U. Theopold. 1989. Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane-associated or secreted forms of β-galactosidase. Immunogenetics 30:296.
23. d are influenced by its amino terminus. J. Immunol. 137:916.
24. d molecules at the cell surface. J Exp. Med 178:2035.
25. 2-microglobulin-deficient mice. J. Immunol. 154:47.
26. Lie, W. R., N. B. Myers, J. Gorka, R. J. Rubocki, J. M. Connolly, and T. H. Hansen. 1990. Peptide ligand-induced conformation and surface expression of the Ld class 1 MHC molecule. Nature 344:439.
27. 2 microglobulin and peptide. Proc. Nail. Acad. Sci. USA 94:6880.
28. Lie, W. R., N. B. Myers, J. M. Connolly, J. Gorka, D. R. Lee, and T. H. Hansen. 1991. The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigenic structure. J. Exp. Med. 173: 449.
29. Carbone, F. R., and M. J. Bevan. 1990. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp. Med. 171:377.
30. Crumpacker, D. B., J. Alexander, P. Cresswell, and V. H. Engelhard. 1992. Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM. T2. J. Immunol. 148:3004.
31. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403.
32. Eisenlohr, L. C., I. Bacik, J. R. Bennink, K. Bernstein, and J. W. Yewdell. 1992. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell 71:963.
33. Del Val, M., H. Volkmer, J. B. Rothbard, S. Jonjic, M Messerle, J. Schickedanz, M. J. Reddehase, and U. H. Koszinowski. 1988. Molecular basis of cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89. J. Virol. 62:3965.
34. Ljunggren, H. G., N. J. Stam, C. Ohlen, J. J. Neefjes, P. Hoglund, M. T. Heemels, J. Bastin, T. N. Schumacher, A. Townsend, K. Karre, et al. 1990. Empty MHC class I molecules come out in the cold. Nature 346:476.
35. Townsend, A., J. Bastin, K. Gould, G. Brownlee, M. Andrew, B. Coupar, D. Boyle, S. Chan, and G. Smith. 1988. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:1211.
36. Bronte, V., M. W. Carroll, T. J. Goletz, M. Wang, W. W. Overwijk, F. Marincola, S. A. Rosenberg, B. Moss, and N. P. Restifo. 1997. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc. Natl. Acad. Sci. USA 94:3183.
37. Yewdell, J. W., and J. R. Bennink. 1989. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science 244:1072.
38. Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726.
39. Rotzschke, O., K. Falk, H. J. Wallny, S. Faath, and H.-G. Rammensee. 1990. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. Science 249:283.
40. Joyce, S. 1997. Traffic control of completely assembled MHC class I molecules beyond the endoplasmic reticulum. J. Mol. Biol. 266:993
41. Weis, J. H., and J. G Seidman. 1985. The expression of major histocompatibility antigens under metallothionein gene promoter control. J. Immunol. 134:1999.
42. Schild, H., D. Arnold-Schild, E. Lammert, and H.-G. Rammensee 1999. Stress proteins and immunity mediated by cytotoxic T lymphocytes. Curr. Op in Immunol. 11-109.
43. Arnold, D., C. Wahl, S. Faath, H. G. Rammensee, and H. Schild. 1997. Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96. J. Exp. Med. 186:461.
44. Lammert, E., D. Arnold, H. G. Rammensee, and H. Schild. 1996. Expression levels of stress protein gp96 are not limiting for major histocompatibility complex class I-restricted antigen presentation. Eur. J. Immunol. 26:875.
45. Prasad, S. A., J. W. Yewdell, A. Porgador, B. Sadasivan, P. Cresswell and J. R. Bennink, 1998. Calnexin expression does not enhance the generation of MHC class I-peptide complexes. Eur. J. Immunol. 28:907.
46. 2m in vivo. Immunogenetics 43: 384.
47. Niedermann, G., S. Butz, H. G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschutzky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class 1 molecules. Immunity 2:289.
48. Eggers, M., B. Boesfabian, T. Ruppert, P. M. Kloetzel, and U. H. Koszinowski. 1995. The cleavage preference of the proteasome governs the yield of antigenic peptides. J Exp. Med. 182:1865.
49. Neefjes, J., E. Gottfried, J. Roelse, M. Gromme, R. Obst, G. J. Hammerling, and F. Momburg. 1995. Analysis of the fine specificity of rat, mouse and human TAP peptide transporters. Eur. J. Immunol. 25:1133.
50. Wu, Y., and T. J. Kipps. 1997. Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome-dependent degradation are highly efficient inducers of cytolytic T lymphocytes. J. Immunol. 159:6037.
51. Momburg, F., J. J. Neefjes, and G. J. Hammerling. 1994. Peptide selection by MHC-encoded TAP transporters. Curr. Opin. Immunol. 6:32.
52. ds: sequence motif, quantitative binding, and molecular modeling of the complex. J. Exp. Med. 176:1681.
53. Rivoltini, L., K. C. Barracchini, V. Viggiano, Y. Kawakami, A. Smith, A. Mixon, N. P. Restifo, S. L. Topalian, T. B. Simonis, S. A. Rosenberg, and F. M. Marincola. 1995. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res. 55:1149.
54. Luescher, I. F., P. Romero, J. C. Cerottini, and I. L. Maryanski. 1991. Specific binding of antigenic peptides to cell-associated MHC class I molecules. Nature 351:72.
55. Yewdell, J. W., L. C. Anton, and J. R. Bennink. 1996. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class 1 molecules? J. Immunol. 157:1823.
56. Malarkannan, S., F. Gonzalez, V. Nguyen, G. Adair, and N. Shastri. 1996. Alloreactive CD8(+) T cells can recognize unusual, rare, and unique processed peptide/MHC complexes. J. Immunol. 157:4464.
57. Sykulev, Y., M. Joo, I. Vturina, T. J. Tsomides, and H. N. Eisen. 1996. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4:565.
58. Butz, E. A., and M. J. Bevan. 1998. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells. J. Immunol. 160:2139.